Finally, our work demonstrates the use of the rabbit polyclonal antibodies, which are by their virtue transiently activating antibodies and have a very high if not absolute efficiency against prostate cancer cells expressing TRPV6 on the plasma membrane. The gene discussed is TRPV6; the disease is prostate carcinoma.